EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New migraine pill shows promise in Long-Term safety trial
Disease control CompletedThis study looked at the long-term safety of a daily pill called atogepant for preventing migraines in people with chronic or episodic migraine. About 596 adults who had already completed a previous atogepant study took the drug for up to 156 weeks (about 3 years). The main goal …
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Daily pill shows promise for migraine prevention in safety trial
Disease control CompletedThis study looked at the safety of taking rimegepant every day to prevent episodic migraines. 441 adults with a history of migraines took the daily pill, and researchers tracked side effects. The goal was to see how well people tolerated long-term daily use of this medication.
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:52 UTC